Screener

Eligibility screening

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial of VENT-03 in Adults with Active Cutaneous Lupus Erythematosus

Sponsored by Ventus Therapeutics U.S., Inc.Study detailsClinicalTrials.gov

10 US sites in CA, FL, MO, NY +2

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.